Biomarkers derived from the proteome and metabolome are therapeutically useful and change rapidly, making them suitable for assessing intervention effects.

“i think the likelihood that we're going to find something in the proteome and the metabolome is is is higher i mean something that's that's that's therapeutically useful yeah just because those things really change rapidly yeah you know and and um if if we want to know if you do x for the if you if you fast six hours you fix facts uh fast 12 hours i think what you're going to look for there is changes in gene activity and and that's going to be in the proteome yeah or or in the metabolism”